Cipla
Search results
Insights from the leading minds in our industry. Explore. The Lupin Foundation works in over 4,500 villages to ensure sustainable development. Our Mission. Delivering on our promise toward innovative science and healthcare for more than five decades. How We Began.
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. The company's key focus areas include paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.
Established in 1968 by our visionary founder, Dr. Desh Bandhu Gupta, Lupin has evolved from humble beginnings to become a global healthcare leader. Headquartered in Mumbai, India, we have expanded our footprint across the U.S., LATAM, APAC and EMEA regions, operating in over 100 countries and offering adiverse portfolio of over 1,000 products.
3 days ago · Lupin Limited Stock Price Today, Live NSE Share Price: Get the latest Lupin Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.
4 days ago · Lupin Share Price Today (25 Jun, 2024): Lupin Stock Price (₹ 1558.85) Live NSE/BSE updates on The Economic Times. Check out why Lupin share price is down today. Get all details on Lupin shares news and analysis, Forecasts, Dividend, balance sheet, profit & loss, Quarterly results, annual report information, and more.
Get the latest Lupin Ltd (LUPIN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Get the latest Lupin Ltd (500257) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Lupin is a global pharmaceutical company offering Branded and Generic Formulations, Biosimilars and Active Pharmaceutical Ingredients (APIs). Founded over 50 years ago, Lupin today is a...
1 day ago · The stock of Lupin Ltd. quoted a 52-week high and 52-week low prices of Rs 1727.9 and Rs 876.1, respectively. The Beta value of the counter, which measures its volatility in relation to the broader market, stood at 0.75. Promotor/FII Holding Promoters held 47.01 per cent stake in the company as of 31-Mar-2024, while FIIs held 18.29 per cent and domestic institutional investors had 27.69 per cent.
Lupin Limited is a transnational pharmaceutical Company. The Company is engaged in producing a range of generic and branded formulations and bulk drugs. It manufactures Active Pharmaceutical ...
